Cerebro-oculo-facio-skeletal syndrome caused by the homozygous pathogenic variant Gly47Arg in ERCC2.


Journal

American journal of medical genetics. Part A
ISSN: 1552-4833
Titre abrégé: Am J Med Genet A
Pays: United States
ID NLM: 101235741

Informations de publication

Date de publication:
03 2021
Historique:
received: 02 07 2020
revised: 09 12 2020
accepted: 12 12 2020
pubmed: 29 12 2020
medline: 20 7 2021
entrez: 28 12 2020
Statut: ppublish

Résumé

DNA damage repair is a pivotal mechanism in life. The nucleotide excision repair pathway protects the cells against DNA damage and involves XPD, an ATP dependent helicase that is part of the multisubunit protein complex TFIIH. XPD is encoded by the excision repair cross-complementation group 2 gene (ERCC2). Only three patients with cerebro-oculo-facio-skeletal syndrome (COFS), caused by mutations in ERCC2, have been published so far. This report describes a boy with the homozygous amino acid change p.Gly47Arg in XPD. He presented with profound microcephaly, psychomotor retardation, failure to thrive, cutaneous photosensitivity, a bilateral hearing deficit and optic atrophy, thrombocytopenia, and recurrent episodes of pneumonia. We report the first homozygous occurrence of the pathogenic variant Gly47Arg in the ERCC2 gene. Occurring homozygous, this variant was associated with COFS syndrome, leading to early death of the patient at the age of 21 months.

Identifiants

pubmed: 33369099
doi: 10.1002/ajmg.a.62048
doi:

Substances chimiques

Xeroderma Pigmentosum Group D Protein EC 3.6.4.12
ERCC2 protein, human EC 5.99.-

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

930-936

Informations de copyright

© 2020 The Authors. American Journal of Medical Genetics Part A published by Wiley Periodicals LLC.

Références

Adzhubei, I. A., Schmidt, S., Peshkin, L., Ramensky, V. E., Gerasimova, A., Bork, P., … Sunyaev, S. R. (2010). A method and server for predicting damaging missense mutations. Nature Methods, 7, 248-249.
Bienstock, R. J., Skorvaga, M., Mandavilli, B. S., & van Houten, B. (2003). Structural and functional characterization of the human DNA repair helicase XPD by comparative molecular modeling and site-directed mutagenesis of the bacterial repair protein UvrB. The Journal of Biological Chemistry, 278, 5309-5316.
Choi, Y., & Chan, A. P. (2015). PROVEAN web server: A tool to predict the functional effect of amino acid substitutions and indels. Bioinformatics, 31, 2745-2747.
Cleaver, J. E., Thompson, L. H., Richardson, A. S., & States, J. C. (1999). A summary of mutations in the UV-sensitive disorders: Xeroderma pigmentosum, Cockayne syndrome, and trichothiodystrophy. Human Mutation, 14, 9-22.
Coin, F., Marinoni, J. C., Rodolfo, C., Fribourg, S., Pedrini, A. M., & Egly, J. M. (1998). Mutations in the XPD helicase gene result in XP and TTD phenotypes, preventing interaction between XPD and the p44 subunit of TFIIH. Nature Genetics, 20, 184-188.
Coin, F., Oksenych, V., & Egly, J.-M. (2007). Distinct roles for the XPB/p52 and XPD/p44 subcomplexes of TFIIH in damaged DNA opening during nucleotide excision repair. Molecular Cell, 26, 245-256.
Compe, E., & Egly, J.-M. (2012). TFIIH: When transcription met DNA repair. Nature Reviews. Molecular Cell Biology, 13, 343-354.
Dubaele, S., Proietti de Santis, L., Bienstock, R. J., Keriel, A., Stefanini, M., van Houten, B., & Egly, J.-M. (2003). Basal transcription defect discriminates between xeroderma pigmentosum and trichothiodystrophy in XPD patients. Molecular Cell, 11, 1635-1646.
Dvir, A., Conaway, R. C., & Conaway, J. W. (1997). A role for TFIIH in controlling the activity of early RNA polymerase II elongation complexes. Proceedings of the National Academy of Sciences of the United States of America, 94, 9006-9010.
Faghri, S., Tamura, D., Kraemer, K. H., & DiGiovanna, J. J. (2008). Trichothiodystrophy: A systematic review of 112 published cases characterises a wide spectrum of clinical manifestations. Journal of Medical Genetics, 45, 609-621.
Fassihi, H., Sethi, M., Fawcett, H., Wing, J., Chandler, N., Mohammed, S., … Lehmann, A. R. (2016). Deep phenotyping of 89 xeroderma pigmentosum patients reveals unexpected heterogeneity dependent on the precise molecular defect. Proceedings of the National Academy of Sciences of the United States of America, 113, E1236-E1245.
Fujimoto, M., Leech, S. N., Theron, T., Mori, M., Fawcett, H., Botta, E., … Lehmann, A. R. (2005). Two new XPD patients compound heterozygous for the same mutation demonstrate diverse clinical features. The Journal of Investigative Dermatology, 125, 86-92.
Gorbalenya, A. E., & Koonin, E. V. (1993). Helicases: Amino acid sequence comparisons and structure-function relationships. Current Opinion in Structural Biology, 3, 419-429.
Graham, J. M., Anyane-Yeboa, K., Raams, A., Appeldoorn, E., Kleijer, W. J., Garritsen, V. H., … Jaspers, N. G. J. (2001). Cerebro-oculo-facio-skeletal syndrome with a nucleotide excision-repair defect and a mutated XPD gene, with prenatal diagnosis in a triplet pregnancy. American Journal of Human Genetics, 69, 291-300.
Guzder, S. N., Qiu, H., Sommers, C. H., Sung, P., Prakash, L., & Prakash, S. (1994). DNA repair gene RAD3 of S. cerevisiae is essential for transcription by RNA polymerase II. Nature, 367, 91-94.
Horibata, K., Kono, S., Ishigami, C., Zhang, X., Aizawa, M., Kako, Y., … Tanaka, K. (2015). Constructive rescue of TFIIH instability by an alternative isoform of XPD derived from a mutated XPD allele in mild but not severe XP-D/CS. Journal of Human Genetics, 60, 259-265.
Keriel, A., Stary, A., Sarasin, A., Rochette-Egly, C., & Egly, J.-M. (2002). XPD mutations prevent TFIIH-dependent transactivation by nuclear receptors and phosphorylation of RARα. Cell, 109, 125-135.
Kondo, D., Noguchi, A., Tamura, H., Tsuchida, S., Takahashi, I., Kubota, H., … Takahashi, T. (2016). Elevated urinary levels of 8-hydroxy-2′-deoxyguanosine in a Japanese child of xeroderma pigmentosum/Cockayne syndrome complex with infantile onset of nephrotic syndrome. The Tohoku Journal of Experimental Medicine, 239, 231-235.
Laugel, V., Dalloz, C., Tobias, E. S., Tolmie, J. L., Martin-Coignard, D., Drouin-Garraud, V., … Dollfus, H. (2008). Cerebro-oculo-facio-skeletal syndrome: Three additional cases with CSB mutations, new diagnostic criteria and an approach to investigation. Journal of Medical Genetics, 45, 564-571.
Natale, V. (2011). A comprehensive description of the severity groups in Cockayne syndrome. American Journal of Medical Genetics. Part A, 155A, 1081-1095.
Oksenych, V., & Coin, F. (2010). The long unwinding road: XPB and XPD helicases in damaged DNA opening. Cell Cycle, 9, 90-96.
Park, J. H., Elpers, C., Reunert, J., McCormick, M. L., Mohr, J., Biskup, S., … Marquardt, T. (2019). SOD1 deficiency: A novel syndrome distinct from amyotrophic lateral sclerosis. Brain, 142, 2230-2237.
Rentzsch, P., Witten, D., Cooper, G. M., Shendure, J., & Kircher, M. (2019). CADD: Predicting the deleteriousness of variants throughout the human genome. Nucleic Acids Research, 47, D886-D894.
Richards, J. D., Cubeddu, L., Roberts, J., Liu, H., & White, M. F. (2008). The archaeal XPB protein is a ssDNA-dependent ATPase with a novel partner. Journal of Molecular Biology, 376, 634-644.
Schaeffer, L., Moncollin, V., Roy, R., Staub, A., Mezzina, M., Sarasin, A., … Egly, J. M. (1994). The ERCC2/DNA repair protein is associated with the class II BTF2/TFIIH transcription factor. The EMBO Journal, 13, 2388-2392.
Schwarz, J. M., Cooper, D. N., Schuelke, M., & Seelow, D. (2014). MutationTaster2: Mutation prediction for the deep-sequencing age. Nature Methods, 11, 361-362.
Seelow, D., Schwarz, J. M., & Schuelke, M. (2008). GeneDistiller-Distilling candidate genes from linkage intervals. PLoS One, 3, e3874.
Spivak, G. (2015). Nucleotide excision repair in humans. DNA Repair, 36, 13-18.
Suzumura, H., & Arisaka, O. (2010). Cerebro-oculo-facio-skeletal syndrome. Experimental Medicine and Biology, 685, 210-214.
Taylor, E. M., Broughton, B. C., Botta, E., Stefanini, M., Sarasin, A., Jaspers, N. G., … Lehmann, A. R. (1997). Xeroderma pigmentosum and trichothiodystrophy are associated with different mutations in the XPD (ERCC2) repair/transcription gene. Proceedings of the National Academy of Sciences of the United States of America, 94, 8658-8663.
Theron, T., Fousteri, M. I., Volker, M., Harries, L. W., Botta, E., Stefanini, M., … Lehmann, A. R. (2005). Transcription-associated breaks in xeroderma pigmentosum group D cells from patients with combined features of xeroderma pigmentosum and Cockayne syndrome. Molecular and Cellular Biology, 25, 8368-8378.
Wilson, B. T., Stark, Z., Sutton, R. E., Danda, S., Ekbote, A. V., Elsayed, S. M., … Wilson, I. J. (2016). The Cockayne syndrome natural history (CoSyNH) study: Clinical findings in 102 individuals and recommendations for care. Genetics in Medicine, 18, 483-493.
Zhang, J., Cheng, R., Yu, X., Sun, Z., Li, M., & Yao, Z. (2017). Expansion of the genotypic and phenotypic spectrum of xeroderma pigmentosum in Chinese population. Photodermatology, Photoimmunology & Photomedicine, 33, 58-63.

Auteurs

Janine Reunert (J)

Universitätsklinikum Münster, Klinik für Kinder und Jugendmedizin, Münster, Germany.

Alijda van den Heuvel (A)

Universitätsklinikum Münster, Klinik für Kinder und Jugendmedizin, Münster, Germany.

Stephan Rust (S)

Universitätsklinikum Münster, Klinik für Kinder und Jugendmedizin, Münster, Germany.

Thorsten Marquardt (T)

Universitätsklinikum Münster, Klinik für Kinder und Jugendmedizin, Münster, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH